Total Payments
$611,402
2024 Payments
$116,178
Companies
11
Transactions
844
Medicare Patients
2,349
Medicare Billing
$276,554
Payment Breakdown by Category
Other$480,755 (78.6%)
Travel$73,840 (12.1%)
Consulting$34,949 (5.7%)
Food & Beverage$21,842 (3.6%)
Education$16.72 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $328,765 | 163 | 53.8% |
| Honoraria | $106,550 | 47 | 17.4% |
| Travel and Lodging | $73,840 | 348 | 12.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $45,440 | 23 | 7.4% |
| Consulting Fee | $34,949 | 20 | 5.7% |
| Food and Beverage | $21,842 | 242 | 3.6% |
| Education | $16.72 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $202,371 | 291 | $0 (2024) |
| UCB, Inc. | $146,940 | 226 | $0 (2024) |
| SK Life Science, Inc. | $95,920 | 110 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $75,059 | 89 | $0 (2019) |
| JAZZ PHARMACEUTICALS INC. | $37,314 | 43 | $0 (2024) |
| Lundbeck LLC | $24,170 | 40 | $0 (2018) |
| Greenwich Biosciences, Inc. | $10,024 | 17 | $0 (2021) |
| Cyberonics, Inc. | $9,017 | 14 | $0 (2017) |
| CATALYST PHARMACEUTICALS, INC. | $4,974 | 4 | $0 (2024) |
| Eisai Inc. | $4,630 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $116,178 | 186 | UCB, Inc. ($59,440) |
| 2023 | $82,956 | 99 | LivaNova USA, Inc. ($30,229) |
| 2022 | $54,167 | 61 | SK Life Science, Inc. ($27,870) |
| 2021 | $32,982 | 46 | SK Life Science, Inc. ($18,295) |
| 2020 | $35,416 | 65 | LivaNova USA, Inc. ($14,824) |
| 2019 | $99,341 | 117 | LivaNova USA, Inc. ($52,563) |
| 2018 | $65,422 | 87 | LivaNova USA, Inc. ($31,219) |
| 2017 | $124,939 | 183 | Sunovion Pharmaceuticals Inc. ($46,189) |
All Payment Transactions
844 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,825.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $56.00 | General |
| Category: Neurology | ||||||
| 11/21/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | Cash or cash equivalent | $52.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | Cash or cash equivalent | $52.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | Cash or cash equivalent | $42.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | Cash or cash equivalent | $42.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | Cash or cash equivalent | $22.53 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | Cash or cash equivalent | $16.37 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | Cash or cash equivalent | $16.37 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | Cash or cash equivalent | $16.02 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | Cash or cash equivalent | $16.01 | General |
| Category: Neurology | ||||||
| 11/18/2024 | UCB, Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| Category: Neurology | ||||||
| 11/06/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: Neurology | ||||||
| 11/06/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $122.75 | General |
| Category: Neurology | ||||||
| 11/06/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $25.46 | General |
| Category: Neurology | ||||||
| 11/04/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $123.52 | General |
| Category: Neurology | ||||||
| 11/01/2024 | UCB, Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| Category: Neurology | ||||||
| 10/31/2024 | UCB, Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 10/30/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $95.84 | General |
| Category: Neurology | ||||||
| 10/29/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | In-kind items and services | $243.48 | General |
| Category: Neurology | ||||||
| 10/29/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | In-kind items and services | $243.47 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 670 | 801 | $457,770 | $72,449 |
| 2022 | 11 | 592 | 688 | $374,184 | $63,001 |
| 2021 | 10 | 504 | 649 | $409,542 | $66,937 |
| 2020 | 12 | 583 | 728 | $439,225 | $74,166 |
Total Patients
2,349
Total Services
2,866
Medicare Billing
$276,554
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 108 | 204 | $228,634 | $35,340 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 103 | $29,528 | $8,789 | 29.8% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 73 | 73 | $52,688 | $7,931 | 15.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 121 | 123 | $37,931 | $5,630 | 14.8% |
| 95939 | Placement of skin electrodes and measurement of central motor stimulation in arms and legs | Facility | 2023 | 46 | 47 | $30,409 | $4,598 | 15.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 69 | 70 | $21,770 | $3,217 | 14.8% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2023 | 78 | 80 | $19,600 | $2,957 | 15.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $7,864 | $1,841 | 23.4% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2023 | 27 | 27 | $8,046 | $1,190 | 14.8% |
| 95870 | Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study | Facility | 2023 | 57 | 60 | $21,300 | $957.39 | 4.5% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 89 | 158 | $177,463 | $27,984 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 109 | $31,466 | $9,201 | 29.2% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 62 | 65 | $47,767 | $7,440 | 15.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 129 | 129 | $40,119 | $6,025 | 15.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 52 | 53 | $16,483 | $2,549 | 15.5% |
| 95939 | Placement of skin electrodes and measurement of central motor stimulation in arms and legs | Facility | 2022 | 24 | 24 | $15,528 | $2,427 | 15.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 14 | $5,744 | $2,057 | 35.8% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2022 | 49 | 49 | $12,005 | $1,897 | 15.8% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2022 | 27 | 28 | $8,344 | $1,362 | 16.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 16 | 16 | $4,000 | $1,343 | 33.6% |
| 95870 | Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study | Facility | 2022 | 39 | 43 | $15,265 | $715.64 | 4.7% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 92 | 204 | $233,784 | $36,041 | 15.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 98 | $30,235 | $8,601 | 28.4% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 56 | 60 | $44,400 | $6,806 | 15.3% |
| 95939 | Insertion of needles and skin electrodes for measurement and recording of stimulated sites in the arms and legs (brain motor stimulation) | Facility | 2021 | 49 | 49 | $31,703 | $4,944 | 15.6% |
About Dr. Micheal Macken, MD
Dr. Micheal Macken, MD is a Clinical Neurophysiology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336110550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Micheal Macken, MD has received a total of $611,402 in payments from pharmaceutical and medical device companies, with $116,178 received in 2024. These payments were reported across 844 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($328,765).
As a Medicare-enrolled provider, Macken has provided services to 2,349 Medicare beneficiaries, totaling 2,866 services with total Medicare billing of $276,554. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Location Chicago, IL
- Active Since 01/27/2006
- Last Updated 12/08/2020
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1336110550
Products in Payments
- VNS Therapy (Device) $150,410
- XCOPRI (Drug) $86,091
- Briviact (Drug) $75,753
- APTIOM (Drug) $75,059
- Fintepla (Drug) $49,237
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $38,479
- EPIDIOLEX (Drug) $37,284
- ONFI (Drug) $24,170
- VNS Therapy SenTiva Model 1000 Generator (Device) $16,831
- Epidiolex (Drug) $10,024
- Cenobamate (Drug) $9,536
- Vimpat (Drug) $7,982
- Nayzilam (Drug) $6,361
- VNS - Sentiva (Device) $5,669
- FYCOMPA (Drug) $4,974
- Fycompa (Drug) $4,630
- ACTIVA (Device) $981.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Neurophysiology Doctors in Chicago
Dr. Sumayyah Abumurad, Md, MD
Clinical Neurophysiology — Payments: $85,391
Clinical Neurophysiology $85,391
Akash Patel, Do, DO
Clinical Neurophysiology — Payments: $6,674
Clinical Neurophysiology $6,674
Ahmad Daif
Clinical Neurophysiology — Payments: $3,637
Clinical Neurophysiology $3,637
Dr. Diana Mnatsakanova, M.d, M.D
Clinical Neurophysiology — Payments: $2,288
Clinical Neurophysiology $2,288
Dr. David Bieber
Clinical Neurophysiology — Payments: $970.59
Clinical Neurophysiology $970.59
Serge Pierre-Louis, M.d, M.D
Clinical Neurophysiology — Payments: $319.59
Clinical Neurophysiology $319.59